查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
歐洲數位 PCR 市場按應用、最終用戶和國家分類 - 分析和預測（2024-2034 年）
市場調查報告書
商品編碼
1681515

歐洲數位 PCR 市場按應用、最終用戶和國家分類 - 分析和預測（2024-2034 年）

Europe Digital PCR Market: Focus on Application, End User, and Country Analysis - Analysis and Forecast, 2024-2034
出版日期: | 出版商: BIS Research | 英文 72 Pages | 商品交期: 1-5個工作天內

價格

歐洲數位 PCR (d-PCR) 市場規模預計將從 2024 年的 1.839 億美元成長到 2034 年的 7.627 億美元，2024-2034 年預測期內的複合年成長率為 15.29%。

由於個人化醫療在篩檢和診斷遺傳疾病方面的應用越來越多，歐洲數位 PCR 市場正在經歷兩位數的成長。這種針對患者的個人化策略在很大程度上依賴數位 PCR（dPCR）來準確識別和測量與各種癌症相關的罕見基因突變。此外，歐洲各地感染疾病的不斷上升也推動了對快速且準確的診斷解決方案的需求。歐洲市場的成長極大地促進了液滴數位 PCR、奈米板技術和微流體平台等技術進步，這些技術進步提高了 dPCR 的功能。

主要市場統計數據
預測期 2024-2034
2024 年評估 1.839億美元
2034 年預測 7.627億美元
複合年成長率 15.29％

由於個人化醫療的普及和對極其精準的診斷的需求，數位 PCR 市場在歐洲正在快速成長。數位 PCR (dPCR) 具有出色的敏感性和特異性，特別適用於識別低豐度遺傳變異以及測量早期診斷和治療監測至關重要的生物標記。感染疾病、遺傳疾病和癌症的增加促使人們對尖端分子診斷技術的投資。

液滴數位 PCR、奈米板技術和微流體平台等技術進步正在顯著提高檢測精度、通量和整合到臨床工作流程的簡易性。此外，由於政府舉措、有利的法律規範以及對醫療保健基礎設施的資金增加，整個非洲大陸的市場採用正在加速。隨著頂尖研究機構和商業領袖不斷聯手打造可靠的、特異性患者的診斷解決方案，歐洲數位 PCR 市場預計將穩定成長。除了改變分子診斷的模式之外，這個充滿活力的市場也為改善患者治療效果的個人化治療方案打開了大門。

總體而言，技術創新、監管支援和不斷發展的臨床需求共同推動歐洲數位 PCR 市場的強勁擴張。此外，預計不斷成長的研究合作和投資將進一步促進數位 PCR 在歐洲的融合。

本報告研究了歐洲數位 PCR 市場，並提供了市場概述、按應用、最終用戶和國家分類的趨勢以及參與市場的公司概況。

目錄

執行摘要

第1章 市場

  • 市場概況
  • 趨勢：當前和未來的影響評估
  • 供應鏈概覽
  • 研發回顧
  • 正在進行的數位 PCR 臨床試驗
  • 監管狀態
  • 市場動態概覽

第2章 區域

  • 區域摘要
  • 促進因素與限制因素
  • 歐洲

第3章市場-競爭基準化分析與公司概況

  • 競爭格局
  • 市場佔有率分析
  • 公司簡介
    • QIAGEN NV
    • F. Hoffmann-La Roche Ltd
    • Merck KGaA
    • Stilla Technologies Inc.
    • SAGA Diagnostics AB
    • JETA Molecular BV.

第4章調查方法

Product Code: BHP2684SS

Introduction to Europe Digital PCR Market

The Europe digital PCR (d-PCR) market is projected to reach $762.7 million by 2034 from $183.9 million in 2024, growing at a CAGR of 15.29% during the forecast period 2024-2034. The market for digital PCRs in Europe has grown by double digits due to the increasing use of personalised medicine for genetic disorder screening and diagnosis. This patient-specific strategy relies heavily on digital PCR (dPCR), which accurately identifies and measures uncommon genetic mutations connected to a range of cancers. Furthermore, the need for quick and precise diagnostic solutions is being fuelled by the growing incidence of infectious diseases throughout Europe. The market's growth in Europe is being greatly aided by technological advancements like droplet digital PCR, nanoplate technology, and microfluidic platforms, which are improving dPCR capabilities.

Market Introduction

KEY MARKET STATISTICS
Forecast Period2024 - 2034
2024 Evaluation$183.9 Million
2034 Forecast$762.7 Million
CAGR15.29%

The market for digital PCR is growing quickly in Europe due to the growing use of personalised medicine and the need for extremely accurate diagnostics. With its remarkable sensitivity and specificity, digital PCR (dPCR) is especially useful for identifying low-abundance genetic mutations and measuring biomarkers that are essential for early diagnosis and treatment monitoring. Increasing rates of infectious diseases, genetic disorders, and cancers have prompted investments in cutting-edge molecular diagnostic technologies.

The accuracy, throughput, and ease of integration of assays into clinical workflows have been greatly enhanced by technological advancements like droplet digital PCR, nanoplate technology, and microfluidic platforms. Furthermore, market adoption has accelerated throughout the continent due to government initiatives, favourable regulatory frameworks, and increased funding for healthcare infrastructure. The European digital PCR market is expected to grow steadily as top research institutes and business leaders keep working together to create reliable, patient-specific diagnostic solutions. In addition to changing the molecular diagnostics landscape, this dynamic market is opening the door for individualised treatment plans that improve patient outcomes.

Overall, the convergence of technological innovation, regulatory support, and evolving clinical demands is driving the digital PCR market's robust expansion in Europe. Additionally, growing research collaborations and investments will further integrate digital PCR in Europe.

Market Segmentation:

Segmentation 1: by Application

  • Clinical and Research Application
  • Environmental Application
  • Other Application

Segmentation 2: by End User

  • Academic and Research Institutes
  • Hospitals and Clinics
  • Diagnostic Centers
  • Pharmaceutical and Biopharmaceutical Companies
  • Other End User

Segmentation 3: by Region

  • Europe
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Rest-of-Europe

How can this report add value to an organization?

Product/Innovation Strategy: The Europe digital PCR market has been extensively segmented based on various categories, such as application, end user, and country. This can help readers understand which segments account for the largest share and which are well-positioned to grow in the coming years.

Growth/Marketing Strategy: Mergers, acquisitions, and product launches accounted for the maximum number of key developments.

Competitive Strategy: The Europe digital PCR market has numerous established players with product portfolios. Key players in the Europe digital PCR market analyzed and profiled in the study involve established players offering products for digital PCR.

Key Market Players and Competition Synopsis

The companies that are profiled have been selected based on inputs gathered from primary experts, who have analyzed company coverage, product portfolio, and market penetration.

Some prominent names established in this market are:

  • QIAGEN N.V.
  • F. Hoffmann-La Roche Ltd
  • Merck KGaA
  • Stilla Technologies Inc.
  • SAGA Diagnostics AB
  • JETA Molecular BV.

Table of Contents

Executive Summary

Scope and Definition

1 Markets

  • 1.1 Market Overview
    • 1.1.1 Workflow of Digital PCR
    • 1.1.2 Comparison of qPCR and dPCR
  • 1.2 Trends: Current and Future Impact Assessment
    • 1.2.1 Integration with Next-Generation Sequencing (NGS)
    • 1.2.2 Increased Real-time Monitoring and Point-of-care Applications of Digital PCR
    • 1.2.3 Increasing Product Launches in d-PCR Ecosystem
  • 1.3 Supply Chain Overview
  • 1.4 Research and Development Review
    • 1.4.1 Patent Filing Trend (by Region)
    • 1.4.2 Patent Filing Trend (by Country)
    • 1.4.3 Patent Filing Trend (by Year)
  • 1.5 Ongoing Digital PCR Clinical Trials
  • 1.6 Regulatory Landscape
    • 1.6.1 European Union
  • 1.7 Market Dynamics Overview
    • 1.7.1 Market Drivers
      • 1.7.1.1 Increasing Adoption of Personalized Medicine for Screening and Diagnostics of Genetic Disorders such as Rare Diseases and Cancer
      • 1.7.1.2 Increasing Incidence of Infectious Diseases
      • 1.7.1.3 Technological Advancement in dPCR to Enhance Market Growth
    • 1.7.2 Market Restraints
      • 1.7.2.1 High Cost of Platforms Associated with Digital-PCR
      • 1.7.2.2 Shortage of Skilled Professionals and Trained Laboratory Technicians
    • 1.7.3 Market Opportunities
      • 1.7.3.1 Increased Use of Digital-PCR-Based Solutions for the Development of Therapeutics Drugs and Comprehensive Treatment Plan
      • 1.7.3.2 Growing Adoption of dPCR in Emerging Markets

2 Regions

  • 2.1 Regional Summary
  • 2.2 Drivers and Restraints
  • 2.3 Europe
    • 2.3.1 Regional Overview
    • 2.3.2 Driving Factors for Market Growth
    • 2.3.3 Factors Challenging the Market
    • 2.3.4 By Application
    • 2.3.5 By End User
    • 2.3.6 France
    • 2.3.7 Germany
    • 2.3.8 U.K.
    • 2.3.9 Spain
    • 2.3.10 Italy
    • 2.3.11 Rest-of-Europe

3 Markets - Competitive Benchmarking & Company Profiles

  • 3.1 Competitive Landscape
    • 3.1.1 Mergers and Acquisitions
    • 3.1.2 Synergistic Activities
    • 3.1.3 Product Launch and Approval Activities
    • 3.1.4 Expansion, Funding, and Other Activities
  • 3.2 Market Share Analysis
  • 3.3 Company Profile
    • 3.3.1 QIAGEN N.V.
      • 3.3.1.1 Overview
      • 3.3.1.2 Top Products/Product Portfolio
      • 3.3.1.3 Top Competitors
      • 3.3.1.4 Target Customers
      • 3.3.1.5 Key Personnel
      • 3.3.1.6 Analyst View
    • 3.3.2 F. Hoffmann-La Roche Ltd
      • 3.3.2.1 Overview
      • 3.3.2.2 Top Products/Product Portfolio
      • 3.3.2.3 Top Competitors
      • 3.3.2.4 Target Customers
      • 3.3.2.5 Key Personnel
      • 3.3.2.6 Analyst View
    • 3.3.3 Merck KGaA
      • 3.3.3.1 Overview
      • 3.3.3.2 Top Products/Product Portfolio
      • 3.3.3.3 Top Competitors
      • 3.3.3.4 Target Customers
      • 3.3.3.5 Key Personnel
      • 3.3.3.6 Analyst View
    • 3.3.4 Stilla Technologies Inc.
      • 3.3.4.1 Overview
      • 3.3.4.2 Top Products/Product Portfolio
      • 3.3.4.3 Top Competitors
      • 3.3.4.4 Target Customers
      • 3.3.4.5 Key Personnel
      • 3.3.4.6 Analyst View
    • 3.3.5 SAGA Diagnostics AB
      • 3.3.5.1 Overview
      • 3.3.5.2 Top Products/Product Portfolio
      • 3.3.5.3 Top Competitors
      • 3.3.5.4 Target Customers
      • 3.3.5.5 Key Personnel
      • 3.3.5.6 Analyst View
    • 3.3.6 JETA Molecular BV.
      • 3.3.6.1 Overview
      • 3.3.6.2 Top Products/Product Portfolio
      • 3.3.6.3 Top Competitors
      • 3.3.6.4 Target Customers
      • 3.3.6.5 Key Personnel
      • 3.3.6.6 Analyst View

4 Research Methodology

  • 4.1 Data Sources
    • 4.1.1 Primary Data Sources
    • 4.1.2 Secondary Data Sources
    • 4.1.3 Data Triangulation
  • 4.2 Market Estimation and Forecast

List of Figures

  • Figure 1: Digital PCR Market, by Region, $Million, 2023, 2029, and 2034
  • Figure 2: Europe Digital PCR Market (by Application), $Million 202, 2029 and 2034
  • Figure 3: Europe Digital PCR Market (by End User), $Million, 2023, 2029, and 2034
  • Figure 4: Key Events to Keep Track of in the Digital PCR Market
  • Figure 5: Supply Chain and Risks within the Supply Chain
  • Figure 6: Digital PCR Market (by Region), January 2020-September 2024
  • Figure 7: Digital PCR Market (by Country), January 2020-September 2024
  • Figure 8: Digital PCR Market (by Year), January 2020-September 2024
  • Figure 9: Impact Analysis of Market Navigating Factors, 2024-2034
  • Figure 10: France Digital PCR Market, $Million, 2023-2034
  • Figure 11: Germany Digital PCR Market, $Million, 2023-2034
  • Figure 12: U.K. Digital PCR Market, $Million, 2023-2034
  • Figure 13: Spain Digital PCR Market, $Million, 2023-2034
  • Figure 14: Italy Digital PCR Market, $Million, 2023-2034
  • Figure 15: Rest-of-Europe Digital PCR Market, $Million, 2023-2034
  • Figure 16: Strategic Initiatives, January 2019-September 2024
  • Figure 17: Share of Strategic Initiatives, January 2019-September 2024
  • Figure 18: Digital PCR Market, Mergers and Acquisitions, January 2019-September 2024
  • Figure 19: Digital PCR Market, Synergistic Activities, January 2019-September 2024
  • Figure 20: Digital PCR Market, Product Launch and Approval Activities, January 2019-September 2024
  • Figure 21: Digital PCR Market, Expansion, Funding, and Other Activities January 2019-September 2024
  • Figure 22: Data Triangulation
  • Figure 23: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 24: Top-Down Approach (Segment-Wise Analysis)
  • Figure 25: Assumptions and Limitations

List of Tables

  • Table 1: Market Snapshot
  • Table 2: Opportunities across Regions
  • Table 3: Digital PCR Market, Share Analysis, 2023
  • Table 4: Comparison of qPCR and dPCR
  • Table 5: Digital PCR Market, Trend Analysis
  • Table 6: Digital PCR Market, Recent Product Launches
  • Table 7: Some of the Ongoing Digital PCR (d-PCR) Clinical Trials
  • Table 8: Funding Allocated for Precision Medicine to Different Agencies Globally
  • Table 9: Cost for Different Commercialized Digital PCR (d-PCR) Platforms
  • Table 10: Digital PCR Market (by Region), $Million, 2023-2034
  • Table 11: Europe Digital PCR Market (by Application), $Million, 2023-2034
  • Table 12: Europe Digital PCR Market (by End User), $Million, 2023-2034
  • Table 13: France Digital PCR Market (by Application), $Million, 2023-2034
  • Table 14: France Digital PCR Market (by End User), $Million, 2023-2034
  • Table 15: Germany Digital PCR Market (by Application), $Million, 2023-2034
  • Table 16: Germany Digital PCR Market (by End User), $Million, 2023-2034
  • Table 17: U.K. Digital PCR Market (by Application), $Million, 2023-2034
  • Table 18: U.K. Digital PCR Market (by End User), $Million, 2023-2034
  • Table 19: Spain Digital PCR Market (by Application), $Million, 2023-2034
  • Table 20: Spain Digital PCR Market (by End User), $Million, 2023-2034
  • Table 21: Italy Digital PCR Market (by Application), $Million, 2023-2034
  • Table 22: Italy Digital PCR Market (by End User), $Million, 2023-2034
  • Table 23: Rest-of-Europe Digital PCR Market (by Application), $Million, 2023-2034
  • Table 24: Rest-of-Europe Digital PCR Market (by End User), $Million, 2023-2034
  • Table 25: Digital PCR Market. Market Share Analysis, 2023